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Abstract: Chloroanilines are widely used in the manufacture of drugs, pesticides and 
industrial intermediates. Among the trichloroanilines, 3,4,5-trichloroaniline (TCA) is the 
most potent nephrotoxicant in vivo. The purpose of this study was to examine the nephrotoxic 
potential of TCA in vitro and to determine if renal biotransformation and/or free radicals 
contributed to TCA cytotoxicity using isolated renal cortical cells (IRCC) from male Fischer 
344 rats as the animal model. IRCC (~4 million cells/mL; 3 mL) were incubated with TCA 
(0, 0.1, 0.25, 0.5 or 1.0 mM) for 60–120 min. In some experiments, IRCC were pretreated with 
an antioxidant or a cytochrome P450 (CYP), flavin monooxygenase (FMO), cyclooxygenase  
or peroxidase inhibitor prior to incubation with dimethyl sulfoxide (control) or TCA (0.5 mM) 
for 120 min. At 60 min, TCA did not induce cytotoxicity, but induced cytotoxicity as early 
as 90 min with 0.5 mM or higher TCA and at 120 min with 0.1 mM or higher TCA,  
as evidenced by increased lactate dehydrogenase (LDH) release. Pretreatment with the CYP 
inhibitor piperonyl butoxide, the cyclooxygenase inhibitor indomethacin or the peroxidase 
inhibitor mercaptosuccinate attenuated TCA cytotoxicity, while pretreatment with FMO 
inhibitors or the CYP inhibitor metyrapone had no effect on TCA nephrotoxicity. Pretreatment 
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with an antioxidant (α-tocopherol, glutathione, ascorbate or N-acetyl-L-cysteine) also reduced 
or completely blocked TCA cytotoxicity. These results indicate that TCA is directly 
nephrotoxic to IRCC in a time and concentration dependent manner. Bioactivation of TCA 
to toxic metabolites by CYP, cyclooxygenase and/or peroxidase contributes to the 
mechanism of TCA nephrotoxicity. Lastly, free radicals play a role in TCA cytotoxicity, 
although the exact nature of the origin of these radicals remains to be determined. 
Keywords: 3,4,5-Trichloroaniline; nephrotoxicity; kidney; Fischer 344 rat; in vitro; antioxidants 
 
1. Introduction 
Chloroanilines are commonly used as chemical intermediates to manufacture dyes, agricultural 
chemicals, drugs and industrial compounds. Exposure to chloroanilines can occur in occupational 
settings, through the release or formation during the metabolism of compounds in mammals [1–3]  
or by the degradation of pesticides in the environment [1,4–6]. In addition, the detection of  
chloroanilines in human urine or blood can be used as a biomarker for exposure to chloroaniline-based  
pesticides [7–10]. The toxicity associated with exposure to mono- and dichloroanilines includes 
hematotoxicity (e.g. methemoglobinemia or anemia) [11–13], splenotoxicity [11,14], hepatotoxicity [15–17] 
and nephrotoxicity [16,18,19]. Because of their adverse health effects and release into the environment 
in agricultural areas following the breakdown of pesticides, chloroanilines are considered priority 
pollutants in environmental risk assessments [20,21]. 
Trichloroanilines have similar uses as the mono- and dichloroanilines, including use in drug 
development [22–24], dye manufacturing [25] and production of agricultural agents [26]. While the 
potential adverse health effects of mono- and dichloroanilines have been studied in some detail, little 
information is available about the toxicity induced by trichloroanilines, including the nephrotoxic 
potential of trichloroanilines or their mechanisms of inducing nephrotoxicity. Lo et al. examined the  
in vivo and in vitro effects of four trichloroanilines (2,3,4-, 2,4,5-, 2,4,6- and 3,4,5-trichloroaniline) on 
the renal function of male Fischer 344 rats [27]. They noted that of the four trichloroanilines tested,  
3,4,5-trichloroaniline (TCA) had the greatest nephrotoxic potential in vivo as evidenced by oliguria, 
increased kidney weight, elevated blood urea nitrogen concentration and altered renal organic ion 
accumulation. In vitro, TCA was also the most potent nephrotoxicant of the four trichloroanilines tested, 
decreasing tetraethylammonium accumulation by renal cortical slices at 1.0 µM concentration [27]. 
Although it is known that metabolites of mono- and dichloroanilines are toxic to the kidney in vivo 
and in vitro [28–31], no studies have examined the role of biotransformation in trichloroaniline 
nephrotoxicity. It is also unknown if the kidney bioactivates parent chloroanilines to nephrotoxic 
metabolites, or if the parent chloroaniline is toxic to the kidney without bioactivation. The purpose of 
this study was to begin to examine the role of biotransformation of a trichloroaniline in the 
nephrotoxicity it produces in vitro as well as determine if free radicals contributed to the cytotoxicity. 
TCA was selected for study because it is the most potent trichloroaniline nephrotoxicant in vivo and  
in vitro. The Fischer 344 rat was selected as the animal model because our previous studies with 
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chloroaniline-induced nephrotoxicity have been conducted in this animal model. The inhibitor 
pretreatments, concentrations and times selected for study were based on previous reports [32–39]. 
2. Results 
2.1. Time and Concentration Cytotoxicity Studies 
To obtain information concerning the nephrotoxic potential of TCA in isolated renal cortical cells 
(IRCC), a concentration response study was performed at 60, 90 and 120 min. IRCC exposed to TCA at 
concentrations up to 1.0 mM for 60 min did not exhibit any cytotoxicity (data not shown). A 90 min 
exposure to TCA at a concentration of 0.5 mM or higher induced cytotoxicity (increased LDH release), 
while at 120 min of exposure, cytotoxicity was evident at a concentration of 0.1 mM TCA or higher 
(Figure 1). Based on these findings, a concentration of 0.5 mM and an exposure time of 120 min were 
selected for use in the antioxidant and inhibitor pretreatment studies. 
Figure 1. Cytotoxic effects of TCA at 90 min (Panel A) and 120 min (Panel B) in isolated 
renal cortical cells (IRCC). An asterisk indicates significantly different from the dimethyl 
sulfoxide (DMSO) control group value, p < 0.05. 
 
2.2. Effects of Antioxidants on 3,4,5-Trichloroaniline (TCA) Cytotoxicity 
The effects of pretreating IRCC with an antioxidant on TCA cytotoxicity was examined next  
(Figure 2). All four antioxidants (α-tocopherol, ascorbate, glutathione and N-acetyl-L-cysteine) provided 
at least some degree of attenuation of TCA cytotoxicity. Glutathione and ascorbate were most effective 
and α-tocopherol was the least effective at attenuating TCA cytotoxicity. 
  
Int. J. Mol. Sci. 2014, 15 20903 
 
 
2.3. Effects of Cytochrome P450 (CYP) and Flavin-containing Monooxygenase (FMO) Inhibition 
The effects of inhibiting cytochrome P450 (CYP) and FMO activity on TCA cytotoxicity was 
examined using nonselective CYP (piperonyl butoxide (PiBX) and metyrapone) and FMO (methimazole 
and N-octylamine) inhibitors. Inhibition of CYPs with PiBX, but not metyrapone, attenuated TCA 
cytotoxicity (Figure 3). Inhibition of FMOs with either methimazole or N-octylamine had no effect on 
TCA induced cell death (Figure 3). 
Figure 2. Effect of antioxidant pretreatment on TCA cytotoxicity at 120 min. An asterisk 
indicates significantly different from the DMSO control group value, p < 0.05. A diamond 
indicates significantly different from the 0.5 mM TCA alone value, p < 0.05. 
 
Figure 3. Effect of flavin-containing monooxygenase (FMO) or cytochrome P450 (CYP) 
inhibition on TCA cytotoxicity at 120 min. An asterisk indicates significantly different from 
the DMSO control group value, p < 0.05. A diamond indicates significantly different from 
the 0.5 mM TCA alone value, p < 0.05. 
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2.4. Effects of Cyclooxygenase and Peroxidase Inhibition 
The effect of inhibiting the cyclooxygenase activity of prostaglandin H synthase on TCA cytotoxicity 
was determined using indomethacin pretreatment, while mercaptosuccinate was used as a general 
peroxidase inhibitor. Both indomethacin pretreatment and mercaptosuccinate pretreatment reduced TCA 
cytotoxicity (Figure 4). 
Figure 4. Effect of cyclooxygenase or peroxidase inhibition on TCA cytotoxicity at 120 min. 
An asterisk indicates significantly different from the DMSO control group value, p < 0.05.  
A diamond indicates significantly different from the 0.5 mM TCA alone value, p < 0.05. 
 
3. Discussion 
This study is the first report to demonstrate the direct cytotoxic effects of TCA on the kidney.  
In a previous study, the in vitro effects of TCA on organic ion transport by renal cortical slices from 
male Fischer 344 rats suggested that TCA could affect renal function, decreasing organic cation 
accumulation at concentrations as low as 1.0 µM, and affecting both organic anion and cation 
accumulation at 1.0 mM [27]. However, TCA is a weakly basic compound. Thus, the possibility existed 
that the effects seen at µM concentrations of TCA in the work by Lo et al. [27], were more related to 
interactions at the organic cation transporter level than cytotoxicity, and that cytotoxicity was not 
observed until TCA concentrations reached mM levels. Results from the present study clearly 
demonstrate that TCA can induce cytotoxicity at µM concentrations, as evidenced by increased LDH 
release at concentrations of TCA as low as 100 µM at 120 min, and that TCA induces cytotoxicity in a 
time and concentration dependent manner. 
The ability of the various inhibitors used in this study to attenuate TCA cytotoxicity suggests that 
metabolites of TCA contribute to TCA nephrotoxicity in vitro. The biotransformation of TCA has only 
been reported in fish [40]. However, based on studies of the metabolism of other chloroanilines in  
rats [41–44], a potential biotransformation pathway for TCA can be proposed which includes acetylation, 
N-oxidation and aromatic ring oxidation (Figure 5). 
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N-Acetylation is catalyzed by cytosolic N-acetyltransferase enzymes, and it is unlikely that any of  
the pretreatments used in this study would alter this biotransformation reaction. In addition, acetylation of 
chloroanilines produces chloroacetanilides, which have greatly reduced nephrotoxic potential in vivo [45]. 
Thus, it is unlikely that acetylation would be a mechanism for bioactivation of 3,4,5-trichloroaniline. 
Oxidation of the aromatic ring to produce 2-amino-4,5,6-trichlorophenol would be a potential 
bioactivation mechanism for TCA, as many aminophenols are known nephrotoxicants [28,29,32,46,47]. 
Production of an aminophenol metabolite of TCA would be catalyzed by CYPs, as McMillan et al.  
found that aromatic ring oxidation of 3,4-dichloroaniline was catalyzed by CYPs [43,44]. Whether  
2-amino-4,5,6-trichlorophenol is produced in the kidney from TCA and contributes to TCA nephrotoxicity 
remains to be determined. However, a structurally-related metabolite, 2-amino-4,5-dichlorophenol, is 
directly toxic renal cortical slices from male Fischer 344 rats [48]. Attenuation of TCA cytotoxicity by 
the CYP inhibitor PiBX suggests that aromatic ring oxidation may be a potential route of TCA 
bioactivation. Nonetheless, the inability of another general CYP inhibitor, metyrapone, to reduce TCA 
cytotoxicity indicates that further study is needed to clarify which CYPs may contribute to TCA 
bioactivation to toxic metabolites and the role of 2-amino-4,5,6-trichlorophenol in TCA nephrotoxicity. 
The use of additional, more specific CYP inhibitors will help define the role and nature of the CYPs 
contributing to the production of toxic metabolites in TCA metabolism. 
Figure 5. Potential metabolic pathways for TCA. NAT, N-acetyltransferase; CYP, 
cytochrome P450; FMO, flavin-containing monooxygenase. 
 
N-Oxidation can be catalyzed by several enzyme systems, including CYPs, FMOs, prostaglandin H 
synthase and peroxidases [44,49–54]. The N-oxidation pathway has the potential to lead to metabolites 
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that could damage cells via multiple pathways (Figure 5). Metabolites, such as the N-hydroxyl and 
nitroso metabolites can redox cycle to produce reactive oxygen species and other free radicals, which 
can damage membranes and lead to oxidative stress [13,55]. In addition, N-hydroxyl and nitroso 
metabolites have the ability to be further activated to form covalent bonds with cellular nucleophiles  
to alter cellular function and led to cell death [56–58]. The ability of PiBX, indomethacin and 
mercaptosuccinate, but not methimazole or N-octylamine, to attenuate TCA cytotoxicity suggests  
that multiple enzyme systems may be involved in bioactivating TCA to toxic metabolites via  
the N-oxidation pathway, but renal FMOs do not appear to contribute to this bioactivation  
mechanism. That N-oxidation would contribute to TCA cytotoxicity is not completely surprising, as  
3,4-dichlorophenylhydroxylamine, the N-oxidation metabolite of 3,4-dichloroaniline, is a known 
nephrotoxicant in vitro to rat renal cortical slices [31]. 
The ability of the four antioxidants to attenuate TCA cytotoxicity suggests that free radicals contribute 
to the mechanism of renal injury induced by TCA. These free radicals may be produced during the 
oxidation of an aromatic amine or its metabolites [59], or as a consequence of redox cycling of 
aminophenol or phenylhydroxylamine/nitrosobenzene metabolites to produce reactive oxygen species 
and oxidative stress [55,60]. Further work is required to determine if either or both of these potential 
pathways explains the mechanism of protection by antioxidants on TCA cytotoxicity. Preliminary work 
with another chloroaniline, 3,5-dichloroaniline, suggests that oxidative stress may not contribute to the  
in vitro nephrotoxicity induced by 3,5-dichloroaniline (unpublished data), but studies with TCA have 
not been conducted to determine how free radicals contribute to TCA nephrotoxicity in vitro and are 
necessary to define the exact role of free radicals in TCA nephrotoxicity. 
It is interesting to note that α-tocopherol, a lipophilic compound, was the weakest of the four 
antioxidants in attenuating TCA nephrotoxicity. It would be expected that α-tocopherol would enter 
IRCC via a passive diffusion mechanism, while renal transporters can promote the accumulation of 
ascorbate, glutathione and N-acetyl-L-cysteine [61–63]. Glutathione can also be accumulated in proximal 
tubular cells via processing at the luminal membrane and re-synthesis from the accumulated amino acids. 
Thus, higher intracellular concentrations of ascorbate, glutathione and N-acetyl-L-cysteine may be 
achieved in IRCC as compared to α-tocopherol. In addition, while all of the antioxidants have the ability 
to scavenge and detoxify a variety of free radicals and reactive oxygen and nitrogen species to varying 
degrees [64], α-tocopherol associates with membranes and appears to have a primary role in preventing 
lipid peroxidation, which can lead to cell death. Thus, if TCA does not induce oxidative stress and lipid 
peroxidation as its primary mechanism for inducing nephrotoxicity, α-tocopherol would be expected to 
be less effective than the other antioxidants used in this study. However, additional studies are needed 
to clarify the role of oxidative stress and lipid peroxidation in TCA nephrotoxicity. 
4. Experimental Section 
4.1. Experimental Animals 
Male Fischer 344 rats (220–280 g) from Hilltop Lab Animals (Scottdale, PA, USA) were used for all 
experiments. All animals were kept under controlled environments consisting of regulated light cycle 
(on 12 h, off 12 h), temperature (21–23 °C), and humidity (40%–55%) and were housed in standard 
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plastic cages (two rats per cage). Animals were allowed to acclimate for at least one week before being 
used in experiments. Purina Rat Chow and water were available ad libitum. The Marshall University 
Institutional Animal Care and Use Committee approved all animal use in this research (Protocol 531; 
approved on 1 February 2013). Studies were performed at an AAALAC (Association for the Assessment 
and Accreditation of Laboratory Animal Care International) accredited facility and all animal care was 
in accordance with the American Association for Laboratory Animal Science (AALAS) Policy on the 
Humane Care and Use of Laboratory Animals [65]. 
4.2. Chemicals 
All chemicals used were of the highest purity available and were purchased from Sigma Aldrich  
(St. Louis, MO, USA). 
4.3. Isolated Renal Cortical Cell (IRCC) Preparation and Treatment 
Naive rats were anesthetized with pentobarbital (75 mg/kg, intraperitoneal and isolated renal cortical 
cells (IRCC) were obtained using the collagenase perfusion method of Jones et al. [66]. Cell viability 
was initially determined by trypan blue (2% w/v) exclusion and lactate dehydrogenase (LDH) release. 
IRCC were counted and re-suspended in Krebs-Henseleit buffer, pH 7.4, containing 25 mM Hepes and 
2% (w/v) bovine serum albumin at a concentration of ~4.0 million cells/mL. IRCC (3 mL) were added 
to a 25 mL polycarbonate Erlenmeyer flask for a 5 min pre-incubation period in a Dubnoff metabolic 
shaking water bath incubator (GCA Corporation, Precision Scientific Group, Chicago, IL, USA) (37 °C, 
60 cycles/min) under a 95% oxygen/5% carbon dioxide atmosphere. IRCC were then exposed to various 
concentrations of TCA (0, 0.1, 0.25, 0.5, or 1.0 mM) for 60, 90 or 120 min. After the incubation period, 
flasks were removed and placed on ice. Samples (0.5 mL) were taken for lactate dehydrogenase (LDH) 
release assays. Briefly, samples were centrifuged (3000× g, 3 min) in a Model 59A Microcentrifuge 
(Fisher Scientific Company, Waltham, MA, USA), the supernatant was decanted and saved, and the 
pellet was disrupted with 1 mL of 10% Triton X-100 solution to release cellular LDH activity. LDH 
activity was then determined in each fraction (supernatant and pellet) as previously described using a 
kinetic assay based on the amount of reduced β-nicotinamide adenine dinucleotide NADH produced 
from β-nicotinamide adenine dinucleotide (NAD) [30]. LDH released was expressed as % of total 
(supernatant plus pellet). 
In separate experiments, IRCC were pretreated with either an antioxidant or an enzyme system 
inhibitor before exposure to 0.5 mM TCA for an additional 120 min as described above. The 
concentrations and pretreatment times for all of the pretreatments are shown in Table 1. 
4.4. Statistics 
Data are presented as mean ± S.E.M. with the number of experiments per assay (N) ≥ 4. Data were 
analyzed by one-way analysis of variance followed by a Student-Newman-Keuls Test. Statistical 
significance was determined at p < 0.05, α = 0.5. 
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Table 1. List of pretreatments and mechanisms/targeted enzyme systems. 
Pretreatment Concentration (mM) Pretreatment Time (min) Mechanism of Action 
N-Acetyl-L-cysteine 2.0 30 Antioxidant 
α-Tocopherol 1.0 5 Antioxidant 
Glutathione 1.0 30 Antioxidant 
Ascorbate 2.0 5 Antioxidant 
Methimazole 1.0 30 FMO Inhibitor 
N-Octylamine 2.0 5 FMO Inhibitor 
Indomethacin 1.0 15 Cyclooxygenase Inhibitor 
Piperonyl Butoxide 1.0 15 Non-specific CYP Inhibitor 
Metyrapone 1.0 5 Non-specific CYP Inhibitor 
Mercaptosuccinate 0.1 15 Peroxidase Inhibitor 
5. Conclusions 
The results of this study demonstrate that TCA is toxic to the kidney in a time and concentration 
dependent manner. Toxicity was evident as early as 90 min with 0.5 mM TCA and with 0.1 mM TCA 
at 120 min. Since several of the enzyme inhibitor pretreatments attenuated 3,4,5-cytotoxicity, 
metabolites appear to contribute to the renal toxicity induced by TCA. Bioactivation of TCA to 
nephrotoxic metabolites via renal CYPs, cyclooxygenase and/or peroxidases, but not FMOs, are 
potential mechanisms of TCA nephrotoxicity. Free radicals also play a role in TCA nephrotoxicity,  
as evidenced by the inhibition of TCA cytotoxicity by antioxidants. However, whether the free radicals 
are intermediates in TCA biotransformation or reactive oxygen species produced during TCA 
metabolism remains to be determined. 
Acknowledgments 
This work was supported in part by National Institutes of Health grant P20GM103434 to the West 
Virginia IDeA Network of Biomedical Research Excellence. 
Author Contributions 
Gary O. Rankin designed the research; Christopher Racine, Dakota Ward, Dianne K. Anestis,  
Travis Ferguson and Debra Preston performed the experiments; Christopher Racine, Debra Preston and 
Dianne Anestis contributed to the analysis of the data; Gary O. Rankin and Christopher Racine wrote 
the paper. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Aizawa, H. Metabolic Maps of Pesticides; Academic Press, Inc.: London, UK, 1989; Volume 2,  
pp. 27–42. 
Int. J. Mol. Sci. 2014, 15 20909 
 
 
2. Ehlhardt, W.J. Metabolism and disposition of the anticancer agent sulfenur in mouse, rat, monkey, 
and human. Drug Metab. Dispos. 1991, 19, 370–375. 
3. Rickert, D.E.; Held, S.D. Metabolism of chloronitrobenzenes by isolated rat hepatocytes.  
Drug Metab. Dispos. 1990, 18, 5–9. 
4. Lee, J.B.; Sohn, H.Y.; Shin, K.S.; Jo, M.S.; Jeon, C.P.; Jang, J.O.; Kim, J.E.; Kwon, G.S. Microbial 
biodegradation and toxicity of vinclozolin and its toxic metabolite 3,5-dichloroaniline. J. Microbiol. 
Biotechnol. 2008, 18, 343–349. 
5. Santos, T.C.R.; Rocha, J.C.; Alonsa, R.M.; Martinez, E.; Ibanez, C.; Barcelo, D. Rapid degradation 
of propanil in rice field crops. Environ. Sci. Technol. 1998, 32, 3479–3484. 
6. Mercadier, C.; Vega, D.; Bastide, J. Chemical and biological transformation of the fungicide 
vinclozolin. J. Agric. Food Chem. 1998, 46, 3817–3822. 
7. Lindh, C.H.; Littorin, M.; Amilon, A.; Jonsson, B.A. Analysis of 3,5-dichloroaniline as a biomarker 
of vinclozolin an iprodione in human urine using liquid chromatography/triple quadrupole mass 
spectrometry. Rapid Commun. Mass Spectrom. 2007, 21, 536–542. 
8. Kutting, B.; Goen, T.; Schwegler, U.; Fromme, H.; Uter, W.; Angerer, J.; Drexler, H. 
Monoarylamines in the general population—A cross-sectional population-based study including 
1004 Bavarian subjects. Int. J. Hyg. Environ. Health 2009, 212, 298–309. 
9. Turci, R.; Barisano, A.; Baldducci, C.; Colosio, C.; Minoia, C. Determination of dichloroanilines 
in human urine by gas chromatography/mass spectrometry: Validation protocol and establishment 
of reference values in a population group living in central Italy. Rapid Commun. Mass Spectrom. 
2006, 20, 2621–2625. 
10. Vitelli, N.; Chiodini, A.; Colosio, C.; de Paschale, G.; Somaruga, C.; Turci, R.; Minoia, C.; 
Brambilla, G.; Colombi, A. Occupational and environmental exposure to anilide and dicarboximide 
pesticides. G. Ital. Med. Lav. Ergon. 2007, 29, 276–277. 
11. Chhabra, R.S.; Thompson, M.; Elwell, M.R.; Greken, D.K. Toxicity of p-chloroaniline in rats  
and mice. Food Chem. Toxicol. 1990, 28, 717–722. 
12. Guilhermino, L.; Soares, A.M.V.M.; Carvalho, A.P.; Lopes, M.C. Acute effects of 3,4-dichloroaniline 
on blood of male Wistar rats. Chemosphere 1998, 37, 619–632. 
13. Valentovic, M.A.; Rogers, B.A.; Meadows, M.K.; Conner, J.T.; Williams, E.; Hong, S.K.;  
Rankin, G.O. Characterization of methemoglobin formation induced by 3,5-dichloroaniline,  
4-amino-2,6-dichlorophenol and 3,5-dichlorophenylhydroxylamine. Toxicology 1997, 118, 23–36. 
14. Ward, J.M.; Reznik, G.; Garner, F.M. Proliferative lesions of the spleen in male F344 rats fed diets 
containing p-chloroaniline. Vet. Pathol. 1980, 17, 200–205. 
15. Valentovic, M.A.; Ball, J.G.; Anestis, D.K.; Beers, K.W.; Madan, E.; Hubbard, J.L.; Rankin, G.O.  
Acute renal and hepatic toxicity of 2-haloanilines in Fischer 344 rats. Toxicology 1992, 75, 121–131. 
16. Valentovic, M.A.; Ball, J.G.; Anestis, D.K.; Rankin, G.O. Comparison of the in vitro toxicity of 
dichloroaniline structural isomers. Toxicol. In Vitro 1995, 9, 75–81. 
17. Valentovic, M.A.; Lo, H.H.; Brown, P.I.; Rankin, G.O. 3,5-Dichloroaniline toxicity in Fischer 344 
rats pretreated with inhibitors and inducers of cytochrome P450. Toxicol. Lett. 1995, 78, 207–214. 
18. Hong, S.K.; Anestis, D.K.; Henderson, T.T.; Rankin, G.O. Haloaniline-induced in vitro nephrotoxicity: 
Effects of 4-haloanilines and 3,5-dihaloanilines. Toxicol. Lett. 2000, 14, 125–133. 
Int. J. Mol. Sci. 2014, 15 20910 
 
 
19. Lo, H.H.; Brown, P.I.; Rankin, G.O. Acute nephrotoxicity induced by isomeric dichloroanilines in 
Fischer 344 rats. Toxicology 1990, 63, 215–231. 
20. Boehncke, A.; Kielhorn, J.; Konnecker, G.; Pohlenz-Michel, C.; Mangelsdorfer, I. Concise 
International Chemical Assessment Document 48—4-Chloroaniline. World Health Organization: 
Geneva, Switzerland, 2003. 
21. Vangnai, A.S.; Kataoka, N.; Soonglerdsongpha, S.; Kalambaheti, C.; Tajima, T.; Kato, J. 
Construction and application of an Escherichia coli bioreporter for aniline and chloroaniline 
detection. J. Ind. Microbiol. Biotechnol. 2012, 39, 1801–1810. 
22. Craciunescu, D.G.; Furlani, A.; Scarcia, V.; Ghirvu, C.; Doadrio, A. On the synthesis, cytostatic 
and antitumor properties of new Pt(II) and Pt(IV) complexes with chloroanilines. Chem. Biol. 
Interact. 1985, 53, 45–56. 
23. Imai, K.; Takahashi, O.; Watanabe, K.; Nakazawa, S.; Yamanaka, H. The effects of antiprostatic 
agents on the accessory sex organs of rats treated with adrenal androgens. Hinyokika Kiyo 1991, 37, 
1669–1676. 
24. Limban, C.; Marutescu, L.; Chifiriuc, M.C. Synthesis, spectroscopic properties and antipathogenic 
activity of new thiourea derivatives. Molecules 2011, 16, 7593–7607. 
25. Peters, A.T.; Yang, S.S. Monoazo disperse dyes derived from mononitro-dichloro-2-
aminobenzothiazoles. Dyes Pigments 1996, 30, 291–299. 
26. Aggarwal, N.; Kumar, R.; Dureja, P.; Rawat, D.S. Schiff bases as potential fungicides and 
nitrification inhibitors. J. Agric. Food Chem. 2009, 57, 8520–8525. 
27. Lo, H.H.; Brown, P.I.; Rankin, G.O. Trichloroaniline effects on renal function in vivo and in vitro. 
Toxicol. Lett. 1991, 57, 319–328. 
28. Hong, S.K.; Valentovic, M.A.; Anestis, D.K.; Ball, J.G.; Brown, P.I.; Rankin, G.O. Nephrotoxicity 
of 4-amino-2-chlorophenol and 2-amino-4-chlorophenol in the Fischer 344 rat. Toxicology 1996, 
110, 47–58. 
29. Hong, S.K.; Anestis, D.K.; Ball, J.G.; Valentovic, M.A.; Brown, P.I.; Rankin, G.O. 4-Amino-2,6-
Dichlorophenol nephrotoxicity in the Fischer 344 rat: Protection by ascorbic acid, AT-125, and 
aminooxyacetic acid. Toxicol. Appl. Pharmacol. 1997, 147, 115–125. 
30. Rankin, G.O.; Racine, C.; Sweeney, A.: Kraynie, A.; Anestis, D.K.; Barnett, J.B. In vitro 
nephrotoxicity induced by propanil. Environ. Toxicol. 2008, 23, 435–442. 
31. Valentovic, M.; Ball, J.G.; Stoll, S.; Rankin, G.O. 3,4-Dichlorophenylhydroxylamine cytotoxicity 
in renal cortical slices from Fischer 344 rats. Toxicology 2001, 162, 149–156. 
32. Lock, E.A.; Cross, T.J.; Schnellmann, R.G. Studies on the mechanism of 4-aminophenol-induced 
toxicity to renal proximal tubules. Hum. Exp. Toxicol. 1993, 12, 383–388. 
33. Baliga, R.; Zhang, Z.; Baliga, M.; Ueda, N.; Shah, S.V. Role of cytochrome P-450 as a source of 
catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998, 54, 1562–1569. 
34. Rodriguez, R.J.; Acosta, D., Jr. N-Deacetyl ketoconazole-induced hepatotoxicity in a primary 
culture system of rat hepatocytes. Toxicology 1997, 117, 123–131. 
35. Valentovic, M.; Meadows, M.K.; Harmon, R.C.; Ball, J.G.; Hong, S.K.; Rankin, G.O.  
2-Amino-5-chlorophenol toxicity in renal cortical slices from Fischer 344 rats: Effects of 
antioxidants and sulfhydryl agents. Toxicol. Appl. Pharmacol. 1999, 161, 1–9. 
Int. J. Mol. Sci. 2014, 15 20911 
 
 
36. O’Brien, P.J.; Siraki, A.G. Accelerated cytotoxicity mechanism screening using drug metabolizing 
enzyme modulators. Curr. Drug Metab. 2005, 6, 101–109. 
37. Lau, S.S.; Monks, T.J. Co-oxidation of 2-bromohydroquinone by renal prostaglandin synthase: 
Modulation of prostaglandin synthesis by 2-bromohrdroquinone and glutathione. Drug Metab. Dispos. 
1987, 15, 801–807. 
38. Katsuda, H.; Yamashita, M.; Katsura, H.; Yu, J.; Waki, Y.; Nagata, N.; Sai, Y.; Miyamoto, K. 
Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect tumor activity.  
Biol. Pharm. Bull. 2010, 33, 1867–1871. 
39. Suzuki, Y.; Sudo, J. Lipid peroxidation and generations of oxygen radicals induced by 
cephalosporin in renal cortical microsomes of rats. Jpn. J. Pharmacol. 1990, 52, 233–243. 
40. De Wolf, W.; Seinen, W.; Hermens, J.L.M. Biotransformation and toxicokinetics of trichloroanilines in 
fish in relation to their hydrophobicity. Arch. Environ. Contam. Toxicol. 1993, 25, 110–117. 
41. Hong, S.K.; Rankin, G.O. Biotransformation of 2-chloroaniline in the Fischer 344 rat: Identification 
of urinary metabolites. Xenobiotica 1998, 10, 985–994. 
42. Ehlhardt, W.J.; Howbert, J.J. Metabolism and disposition of p-chloroaniline in rat, mouse and 
monkey. Drug Metab. Dispos. 1991, 19, 366–369. 
43. McMillan, D.C.; Freeman, J.P.; Hinson, J.A. Metabolism of the arylamide herbicide propanil. I. 
Microsomal metabolism and in vitro methemoglobinemia. Toxicol. Appl. Pharmacol. 1990, 103, 
90–101. 
44. McMillan, D.C.; Leakey, J.E.; Arlotto, M.P.; McMillan, J.M.; Hinson, J.A. Metabolism of the 
arylamide herbicide propanil. II. Effects of propanil and its derivatives on hepatic microsomal drug 
metabolizing enzymes in the rat. Toxicol. Appl. Pharmacol. 1990, 103, 102–112. 
45. Rankin, G.O.; Valentovic, M.A.; Beers, K.W.; Nicoll, D.W.; Ball, J.G.; Anestis, D.K.; Brown, P.I.; 
Hubbard, J.L. Renal and hepatic toxicity of monochloroacetanilides in the Fischer 344 rat. 
Toxicology 1993, 79, 181–193. 
46. Rankin, G.O.; Valentovic, M.A.; Nicoll, D.W.; Ball, J.G.; Anestis, D.K.; Wang, R.T.; Brown, P.I. 
In vivo and in vitro 4-amino-2,6-dichlorophenol nephrotoxicity and hepatotoxicity in the Fischer 
344 rat. Toxicology 1994, 90, 115–128. 
47. Rankin, G.O.; Hong, S.K.; Anestis, D.K.; Ball, J.G.; Valentovic, M.A. Mechanistic aspects of  
4-amino-2,6-dichlorophenol-induced in vitro nephrotoxicity. Toxicology 2008, 245, 123–129. 
48. Valentovic, M.A.; Ball, J.G.; Sun, H.; Rankin, G.O. Characterization of 2-amino-4,5-dichlorophenol 
(2A45CP) in vitro toxicity in renal cortical slices from male Fischer 344 rats. Toxicology 2002, 172, 
113–123. 
49. Ochiai, Y.; Sakurai, E.; Nomura, A.; Itoh, K.; Tanaka, Y. Metabolism of nicotine in rat lung 
microvascular endothelial cells. J. Pharm. Pharmacol. 2006, 58, 403–407. 
50. Sun, H.; Ehlhardt, W.J.; Kulanthaivel, P.; Lanza, D.L.; Reilly, A.; Yost, G.S. Dehydrogenation of 
indoline by cytochrome P450 enzymes: A novel “aromatase” process. J. Pharmacol. Exp. Ther. 
2007, 322, 843–851. 
51. Yanni, S.B.; Annaert, P.P.; Augustijns, P.; Ibrahim, J.G.; Benjamin, D.K., Jr.; Thakker, D.R.  
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: 
Role of CYP2C19 and flavin-containing monooxygenase 3. Drug Metab. Dispos. 2010, 38, 25–31. 
Int. J. Mol. Sci. 2014, 15 20912 
 
 
52. Golly, I.; Hlavica, P. N-Oxidation of 4-chloroaniline by prostaglandin synthase. Biochem. J. 1985, 
260, 803–809. 
53. Corbett, M.D.; Chipko, B.R.; Batchelor, A.O. The action of chloride peroxidase on 4-chloroaniline. 
Biochem. J. 1980, 187, 893–903. 
54. Bakkenist, A.R.J.; Plat, H.; Wever, R. Oxidation of 4-chloroaniline catalyzed by human 
myeloperoxidase. Bioorg. Chem. 1981, 10, 324–328. 
55. Umbreit, J. Methemoglobin—It’s not just blue: A concise review. Am. J. Hematol. 2007, 82, 134–144. 
56. Kiese, M.; Taeger, K. The fate of phenylhydroxylamine in human red cells. Naunyn Schmiedeberg’s 
Arch. Pharmacol. 1976, 292, 59–66. 
57. Eyer, P.; Ascherl, M. Reactions of para-substituted nitrosobenzenes with human hemoglobin.  
Biol. Chem. 1987, 368, 285–294. 
58. Stiborova, M.; Frei, E.; Schmeiser, H.H.; Wiessler, M.; Anzenbacher, P. Peroxidase oxidizes  
N-nitrosomethylaniline to ultimate carcinogens: Binding to DNA and transfer RNA in vitro.  
Cancer Lett. 1992, 63, 53–59. 
59. Loew, G.H.; Goldblum, A. Metabolic activation and toxicity of acetaminophen and related analogs: 
A theoretical study. Mol. Pharmacol. 1985, 27, 375–386. 
60. Harmon, R.C.; Kiningham, K.K.; Valentovic, M.A. Pyruvate reduces 4-aminophenol in vitro 
toxicity. Toxicol. Appl. Pharmacol. 2006, 213, 179–118. 
61. Lee, J.H.; Oh, C.S.; Mun, G.H.; Kim, J.H.; Chung, Y.H.; Hwang, Y.I.; Shin, D.H.; Lee, W.J. 
Immunohistochemical localization of sodium-dependent L-ascorbic acid transporter 1 protein in rat 
kidney. Histochem. Cell Biol. 2006, 126, 491–494. 
62. Lash, L.H. Renal membrane transport of glutathione in toxicology and disease. Vet. Path. 2011, 48, 
408–419. 
63. Koh, A.S.; Simmons-Willis, T.A.; Pritchard, J.B.; Grassl, S.M.; Ballatori, N. Identification of a 
mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate 
enhance urinary metal excretion: Transport by the renal organic anion transporter. Mol. Pharmacol. 
2002, 62, 921–926. 
64. Machlin, L.J.; Bendich, A. Free radical tissue damage: Protective role of antioxidant nutrients. 
FASEB J. 1987, 1, 441–445. 
65. American Association for Laboratory Animal Science. Humane Care and Use of Laboratory 
Animals. Available online: https://www.aalas.org/about-aalas/position-papers/humane-care-and-
use#.VGDjlE10yfA (accessed on 1 February 2013). 
66. Jones, D.P.; Sundby, G-B.; Ormsted, K.; Orrenius, S. Use of isolated kidney cells for study of drug 
metabolism. Biochem. Pharmacol. 1979, 28, 929–935. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
